Fibroblast growth factor receptor 1 extracellular vesicle as novel therapy for osteoarthritis

Fibroblast growth factor receptor 1 extracellular vesicle as novel therapy for osteoarthritis

Автор: De Liyis Bryan Gervais, Nolan John, Maharjana Made Agus

Журнал: Гений ортопедии @geniy-ortopedii

Рубрика: Оригинальные статьи

Статья в выпуске: 6 т.27, 2021 года.

Бесплатный доступ

Introduction Osteoarthritis (OA) is a joint condition that causes significant impairment of the chondrocyte. The gradual degradation of the cartilage lining of one or more freely moving joints, as well as persistent inflammation, are the causes of osteoarthritis. Current medication focuses on alleviating symptoms rather than curing the condition. Methods This review article was completed by searching for information with the keywords “Fibroblast Growth Factor Receptor-1”, “Extracellular Vesicle”, and “Osteoarthritis” in various journals in several search engines. Out of 102 publications found, 95 were suitable to be studied. Results The upregulated amount of fibroblast growth factor receptors (FGFR1) signaling suggesting the progression of degenerative cartilage that commonly seen in osteoarthritis (OA) patients. Several studies showed that the involvement of extracellular vesicles (EV) derived from MSCs could enhance cartilage repair and protect the cartilage from degradation. EVs have the potential to deliver effects to specific cell types through ligand-receptor interactions and several pathway mechanisms related with the FGFR1. EVs and FGFR1 have been postulated in recent years as possible therapeutic targets in human articular cartilage. Conclusions The protective benefits on both chondrocytes and synoviocytes in OA patients can be achieved by administering the MSC-EVs that may also stimulate chondrocyte proliferation and migration. EVs have a promising potential to become a novel therapy for treating patients with OA. However, further research is needed to discover possible application of this therapy.

Еще

Fibroblast growth factor receptor 1, extracellular vesicle, osteoarthritis

Короткий адрес: https://sciup.org/142231563

IDR: 142231563   |   DOI: 10.18019/1028-4427-2021-27-6-693-699

Список литературы Fibroblast growth factor receptor 1 extracellular vesicle as novel therapy for osteoarthritis

  • Marks R. Knee Osteoarthritis Psychological Complications: An Important Overlooked Disease Correlate // Nov. Tech. Arthritis Bone Res. 2017. Vol. 1, No 4.
  • Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies / A. Cui, H. Li, D. Wang, J. Zhong, Y. Chen, H. Lu // EClinicalMedicine. 2020. Vol. 29-30. P. 100587. DOI: 10.1016/j.eclinm.2020.100587.
  • Lo J., Chan L., Flynn S. A Systematic Review of the Incidence, Prevalence, Costs, and Activity and Work Limitations of Amputation, Osteoarthritis, Rheumatoid Arthritis, Back Pain, Multiple Sclerosis, Spinal Cord Injury, Stroke, and Traumatic Brain Injury in the United States: A 2019 Update // Arch. Phys. Med. Rehabil. 2021. Vol. 102, No 1. P. 115-131. DOI: 10.1016/j.apmr.2020.04.001.
  • Real-World Health Care Resource Utilization and Costs Among US Patients with Knee Osteoarthritis Compared with Controls / A.V. Bedenbaugh, M. Bonafede, E.H. Marchlewicz, V. Lee, J. Tambiah // Clinicoecon. Outcomes Res. 2021. Vol. 13. P. 421-435. DOI: 10.2147/CEOR.S302289.
  • Hunter D.J., Bierma-Zeinstra S. Osteoarthritis // Lancet. 2019. Vol. 393, No 10182. P. 1745-1759. DOI: 10.1016/S0140-6736(19)30417-9.
  • Current Concepts in Osteoarthritis of the Ankle: Review / H. Khlopas, A. Khlopas, L.T. Samuel, E. Ohliger, A.A. Sultan, M. Chughtai, M.A. Mont // Surg. Technol. Int. 2019. Vol. 35. P. 280-294.
  • Osteoarthritis: From complications to cure / M. Khalid, S. Tufail, Z. Aslam, A. Butt // Int. J. Clin. Rheumatol. 2017. Vol. 12, No 6. DOI: 10.4172/17584272.1000152.
  • The impact of hip and knee osteoarthritis on the subsequent risk of incident diabetes: a population-based cohort study / T. Kendzerska, L.K. King, L. Lipscombe, R. Croxford, I. Stanaitis, G.A. Hawker // Diabetologia. 2018. Vol. 61, No 11. P. 2290-2299. DOI: 10.1007/s00125-018-4703-2.
  • Health Quality Ontario. Structured Education and Neuromuscular Exercise Program for Hip and/or Knee Osteoarthritis: A Health Technology Assessment // Ont. Health Technol. Assess. Ser. 2018. Vol. 18, No 8. P. 1-110.
  • Hermann W., Lambova S., Muller-Ladner U. Current Treatment Options for Osteoarthritis // Curr. Rheumatol Rev. 2018. Vol. 14, No 2. P. 108-116. DOI: 10.2174/1573397113666170829155149.
  • Rodriguez-Merchan E.C. Topical therapies for knee osteoarthritis // Postgrad. Med. 2018. Vol. 130, No 7. P. 607-612. DOI: 10.1080/00325481.20 18.1505182.
  • Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis / B.R. da Costa, S. Reichenbach, N. Keller, L. Nartey, S. Wandel, P. Jüni, S. Trelle // Lancet. 2017. Vol. 390, No 10090. P. e21-e33. DOI: 10.1016/S0140-6736(17)31744-0.
  • Non-steroidal anti-inflammatory drugs dampen the cytokine and antibody response to SARS-CoV-2 Infection / J.S. Chen, M.M. Alfajaro, R.D. Chow, J. Wei, R.B. Filler, S.C. Eisenbarth, C.B. Wilen // J. Virol. 2021. Vol. 95, No 7. P. e00014-e00021. DOI: 10.1128/JVI.00014-21.
  • Synergistic Effects of FGF-18 and TGF-ß3 on the Chondrogenesis of Human Adipose-Derived Mesenchymal Stem Cells in the Pellet Culture / L. Huang, L. Yi, C. Zhang, Y. He, L. Zhou, Y. Liu, L. Qian, S. Hou, T. Weng // Stem Cells Int. 2018. Vol. 2018. P. 7139485. DOI: 10.1155/2018/7139485.
  • Fibroblast Growth Factor Receptors (FGFRs): Structures and Small Molecule Inhibitors / S. Dai, Z. Zhou, Z. Chen, G. Xu, Y. Chen // Cells. 2019. Vol. 8, No 6. P. 614. DOI: 10.3390/cells8060614.
  • Fibroblast growth factors: Potential novel targets for regenerative therapy of osteoarthritis / T.M. Chen, Y.H. Chen, H.S. Sun, S.J. Tsai // Chin. J. Physiol. 2019. Vol. 62, No 1. P. 2-10. DOI: 10.4103/CJP.CJP_11_19.
  • Loss of Fgfr1 in chondrocytes inhibits osteoarthritis by promoting autophagic activity in temporomandibular joint / Z. Wang, J. Huang, S. Zhou, F. Luo, Q. Tan, X. Sun, Z. Ni, H. Chen, X. Du, Y. Xie, L. Chen // J. Biol. Chem. 2018. Vol. 293, No 23. P. 8761-8774. DOI: 10.1074/jbc.RA118.002293.
  • Mesenchymal stem cells derived exosomes and microparticles protect cartilage and bone from degradation in osteoarthritis / S. Cosenza, M. Ruiz, K. Toupet, C. Jorgensen, D. Noël // Sci. Rep. 2017. Vol. 7, No 1. P. 16214. DOI: 10.1038/s41598-017-15376-8.
  • MSC exosomes mediate cartilage repair by enhancing proliferation, attenuating apoptosis and modulating immune reactivity / S. Zhang, S.J. Chuah, R.C. Lai, J.H.P. Hui, S.K. Lim, W.S. Toh // Biomaterials. 2018. Vol. 156. P. 16-27. DOI: 10.1016/j.biomaterials.2017.11.028.
  • Maas S.L.N., Breakefield X.O., Weaver A.M. Extracellular Vesicles: Unique Intercellular Delivery Vehicles // Trends Cell Biol. 2017. Vol. 27, No 3. P. 172-188. DOI: 10.1016/j.tcb.2016.11.003.
  • Extracellular vesicles as a platform for membrane-associated therapeutic protein delivery / Y. Yang, Y. Hong, E. Cho, G.B. Kim, I.S. Kim // J. Extracell. Vesicles. 2018. Vol. 7, No 1. P. 1440131. DOI: 10.1080/20013078.2018.1440131.
  • Arthritis / S. Senthelal, J. Li, A. Goyal, P. Bansal, M.A. Thomas // Treasure Island (FL): StatPearls Publishing LLC. 2021.
  • Latourte A., Kloppenburg M., Richette P. Emerging pharmaceutical therapies for osteoarthritis // Nat. Rev. Rheumatol. 2020. Vol. 16, No 12. P. 673688. DOI: 10.1038/s41584-020-00518-6.
  • Grassel S., Aszodi A. Osteoarthritis and Cartilage Regeneration: Focus on Pathophysiology and Molecular Mechanisms // Int. J. Mol. Sci. 2019. Vol. 20, No 24. P. 6156. DOI: 10.3390/ijms20246156.
  • Pathogenesis of Osteoarthritis: Risk Factors, Regulatory Pathways in Chondrocytes, and Experimental Models / Y. He, Z. Li, P.G. Alexander, B.D. Ocasio-Nieves, L. Yocum, H. Lin, R.S. Tuan // Biology (Basel). 2020. Vol. 9, No 8. P. 194. DOI: 10.3390/biology9080194.
  • Osteoarthritis / J. Martel-Pelletier, A.J. Barr, F.M. Cicuttini, P.G. Conaghan, C. Cooper, M.B. Goldring, S.R. Goldring, G. Jones, A.J. Teichtahl, J.P. Pelletier // Nat. Rev. Dis. Primers. 2016. Vol. 2. P. 16072. DOI: 10.1038/nrdp.2016.72.
  • Articular cartilage: from formation to tissue engineering / S. Camarero-Espinosa, B. Rothen-Rutishauser, E.J. Foster, C. Weder // Biomater. Sci. 2016. Vol. 4, No 5. P. 734-767. DOI: 10.1039/c6bm00068a.
  • Hu Q., Ecker M. Overview of MMP-13 as a Promising Target for the Treatment of Osteoarthritis // Int. J. Mol. Sci. 2021. Vol. 22, No 4. P. 1742. DOI: 10.3390/ijms22041742.
  • Leukocyte-rich PRP for knee osteoarthritis: Current concepts / J.F. Lana, A. Macedo, I.L.G. Ingrao, S.C. Huber, G.S. Santos, M.H.A. Santana // I. Clin. Orthop. Trauma. 2019. Vol. 10, No Suppl. 1. P. S179-S182. DOI: 10.1016/j.jcot.2019.01.011.
  • Adverse event following platelet rich plasma injection for the management of early Osteoarthritis of knee - A report of 4 cases / B. Nayak, H.S. Sakale, A.C. Agrawal, B. Kar, R.N. Dash, S.K. Yadav // IP Int. J. Orthop. Rheumatol. 2021. Vol. 7, No 1. P. 42-45. D01:10.18231/j.ijor.2021.010.
  • Fibroblast growth factor control of cartilage homeostasis / M.B. Ellman, D. Yan, K. Ahmadinia, D. Chen, H.S. An, HJ. Im // J. Cell Biochem. 2013. Vol. 114, No 4. P. 735-742. DOI: 10.1002/jcb.24418.
  • Fibroblast growth factor signalling in osteoarthritis and cartilage repair / Y. Xie, A. Zinkle, L. Chen, M. Mohammadi // Nat. Rev. Rheumatol. 2020. Vol. 16, No 10. P. 547-564. DOI: 10.1038/s41584-020-0469-2.
  • Mechanistic Insight Into the Roles of Integrins in Osteoarthritis / H. Jin, S. Jiang, R. Wang, Y. Zhang, J. Dong, Y. Li // Front. Cell Dev. Biol. 2021. Vol. 9. P. 693-484. DOI: 10.3389/fcell.2021.693484.
  • Investigation of wear particles generated in human knee joints using atomic force microscopy / M. Wang, Z. Peng, K. Vasilev, N. Ketheesan // Tribology Letters. 2013. Vol. 51, No 1. P. 161-170. DOI: 10.1007/s11249-013-0160-8.
  • Man G.S., Mologhianu G. Osteoarthritis pathogenesis - a complex process that involves the entire joint // J. Med. Life. 2014. Vol. 7, No 1. P. 37-41.
  • FGF/FGFR signaling in health and disease / Y. Xie, N. Su, J. Yang, Q. Tan, S. Huang, M. Jin, Z. Ni, B. Zhang, D. Zhang, F. Luo, H. Chen, X. Sun, J.Q. Feng, H. Qi, L. Chen // Signal. Transduct. Target Ther. 2020. Vol. 5, No 1. P. 181. DOI: 10.1038/s41392-020-00222-7.
  • A novel FGFR1-binding peptide attenuates the degeneration of articular cartilage in adult mice / Q. Tan, B. Chen, Q. Wang, W. Xu, Y. Wang, Z. Lin, F. Luo, S. Huang, Y. Zhu, N. Su, M. Jin, C. Li, L. Kuang, H. Qi, Z. Ni, Z. Wang, X. Luo, W. Jiang, H. Chen, S. Chen, F. Li, B. Zhang, J. Huang, R. Zhang, K. Jin, X. Xu, C. Deng, X. Du, Y. Xie, L. Chen // Osteoarthritis Cartilage. 2018. Vol. 26, No 12. P. 1733-1743. DOI: 10.1016/j. joca.2018.08.012.
  • Loss of Fgfr1 in chondrocytes inhibits osteoarthritis by promoting autophagic activity in temporomandibular joint / Z. Wang, J. Huang, S. Zhou, F. Luo, Q. Tan, X. Sun, Z. Ni, H. Chen, X. Du, Y. Xie, L. Chen // J. Biol. Chem. 2018. Vol. 293, No 23. P. 8761-8774. DOI: 10.1074/jbc.RA118.002293.
  • Runx2 plays a central role in Osteoarthritis development / D. Chen, D.J. Kim, J. Shen, Z. Zou, R.J. O'Keefe // J. Orthop. Translat. 2019. Vol. 23. P. 132-139. DOI: 10.1016/j.jot.2019.11.008.
  • The identification of CD163 expressing phagocytic chondrocytes in joint cartilage and its novel scavenger role in cartilage degradation / K. Jiao, J. Zhang, M. Zhang, Y. Wei, Y. Wu, Z.Y. Qiu, J. He, Y. Cao, J. Hu, H. Zhu, L.N. Niu, X. Cao, K. Yang, M.Q. Wang // PLoS One. 2013. Vol. 8, No 1. P. e53312. DOI: 10.1371/journal.pone.0053312.
  • Macrophage: A Potential Target on Cartilage Regeneration / T.L. Fernandes, A.H. Gomoll, C. Lattermann, A.J. Hernandez, D.F. Bueno, M.T. Amano // Front. Immunol. 2020. Vol. 11. P. 111. DOI: 10.3389/fimmu.2020.00111.
  • Targeting Runx2 expression in hypertrophic chondrocytes impairs endochondral ossification during early skeletal development / M. Ding, Y. Lu, S. Abbassi, F. Li, X. Li, Y. Song, V. Geoffroy, H.J. Im, Q. Zheng // J. Cell Physiol. 2012. Vol. 227, No 10. P. 3446-3456. DOI: 10.1002/jcp.24045.
  • Cryptotanshinone protects against IL-1 ß-induced inflammation in human osteoarthritis chondrocytes and ameliorates the progression of osteoarthritis in mice / Z. Feng, W. Zheng, X. Li, J. Lin, C. Xie, H. Li, L. Cheng, A. Wu, W. Ni // Int. Immunopharmacol. 2017. Vol. 50. P. 161-167. DOI: 10.1016/j. intimp.2017.06.017.
  • Sun H.Y., Hu K.Z., Yin Z.S. Inhibition of the p38-MAPK signaling pathway suppresses the apoptosis and expression of proinflammatory cytokines in human osteoarthritis chondrocytes // Cytokine. 2017. Vol. 90. P. 135-143. DOI: 10.1016/j.cyto.2016.11.002.
  • Anti-Inflammatory Effect of Geniposide on Osteoarthritis by Suppressing the Activation of p38 MAPK Signaling Pathway / Y. Chen, K. Shou, C. Gong, H. Yang, Y. Yang, T. Bao // Biomed. Res. Int. 2018. Vol. 2018. P. 8384576. DOI: 10.1155/2018/8384576.
  • Fibroblast growth factor receptor 1 is principally responsible for fibroblast growth factor 2-induced catabolic activities in human articular chondrocytes / D. Yan, D. Chen, S.M. Cool, A.J. van Wijnen, K. Mikecz, G. Murphy, H.J. Im // Arthritis Res. Ther. 2011. Vol. 13, No 4. P. R130. DOI: 10.1186/ar3441.
  • A novel fibroblast growth factor receptor 1 inhibitor protects against cartilage degradation in a murine model of osteoarthritis / W. Xu, Y. Xie, Q. Wang, F. Luo, S. Zhou, Z. Wang, J. Huang, Q. Tan, M. Jin, H. Qi, J. Tang, L. Chen, X. Du, C. Zhao, G. Liang, L. Chen // Sci. Rep. 2016. Vol. 6. P. 24042. DOI: 10.1038/srep24042.
  • Enhancement of chondrocyte autophagy is an early response in the degenerative cartilage of the temporomandibular joint to biomechanical dental stimulation / M. Zhang, J. Zhang, L. Lu, Z.Y. Qiu, X. Zhang, S.B. Yu, Y.P. Wu, M.Q. Wang // Apoptosis. 2013. Vol. 18, No 4. P. 423-434. DOI: 10.1007/s10495-013-0811-0.
  • FGFR antagonist induces protective autophagy in FGFR1-amplified breast cancer cell / Y. Chen, X. Xie, X. Li, P. Wang, Q. Jing, J. Yue, Y. Liu, Z. Cheng, J. Li, H. Song, G. Li, R. Liu, J. Wang // Biochem. Biophys. Res. Commun. 2016. Vol. 474, No 1. P. 1-7. DOI: 10.101~6/j.bbrc.2016.03.017.
  • Extracellular vesicles are integral and functional components of the extracellular matrix / K. Rilla, A. Mustonen, U. Arasu, K. Härkönen, J. Matilainen, P. Nieminen // Matrix Biol. 2019. Vol. 75-76. P. 201-219. DOI: 10.1016/j.matbio.2017.10.003.
  • Biological properties of extracellular vesicles and their physiological functions / M. Yáñez-Mó, P. Siljander, Z. Andreu, A.B. Zavec, F.E. Borras, E.I. Buzas, K. Buzas, E. Casal, F. Cappello, J. Carvalho, E. Colás, A. Cordeiro-da Silva, S. Fais, J.M. Falcon-Perez, I.M. Ghobrial, B. Giebel, M. Gimona, M. Graner, I. Gursel, M. Gursel, N.H. Heegaard, A. Hendrix, P. Kierulf, K. Kokubun, M. Kosanovic, V. Kralj-Iglic, E.M. Krämer Albers, S. Laitinen, C. Lässer, T. Lener, E. Ligeti, A. Liné, G. Lipps, A. Llorente, J. Lötvall, M. Mancek-Keber, A. Marcilla, M. Mittelbrunn, I. Nazarenko, E.N. Nolte-'t Hoen, T.A. Nyman, L. O'Driscoll, M. Olivan, C. Oliveira, É. Pállinger, H.A. Del Portillo, J. Reventós, M. Rigau, E. Rohde, M. Sammar, F. Sánchez-Madrid, N. Santarém, K. Schallmoser, M.S. Ostenfeld, W. Stoorvogel, R. Stukelj, S.G. van der Grein, M.H. Vasconcelos, M.H. Wauben, O. De Wever // J. Extracell. Vesicles. 2015. No 4. P. 27066. DOI: 10.3402/jev.v4.27066.
  • Exosomes: roles and therapeutic potential in osteoarthritis / Z. Ni, S. Zhou, S. Li, L. Kuang, H. Chen, X. Luo, J. Ouyang, M. He, X. Du, L. Chen // Bone Res. 2020. Vol. 8. P. 25. DOI: 10.1038/s41413-020-0100-9.
  • Neutrophil-derived microvesicles enter cartilage and protect the joint in inflammatory arthritis / S.E. Headland, H.R. Jones, L.V. Norling, A. Kim, P.R. Souza, E. Corsiero, C.D. Gil, A. Nerviani, F. Dell'Accio, C. Pitzalis, S.M Oliani, L.Y. Jan, M. Perretti // Sci. Transl. Med. 2015. Vol. 7, No 315. P. 315ra190. DOI: 10.1126/scitranslmed.aac5608.
  • Mustonen A.M., Nieminen P. Extracellular vesicles and their potential significance in the pathogenesis and treatment of osteoarthritis // Pharmaceuticals (Basel). 2021. Vol. 14, No 4. P. 315. DOI: 10.3390/ph14040315.
  • Brodkin K.R., Garcia A.J., Levenston M.E. Chondrocyte phenotypes on different extracellular matrix monolayers // Biomaterials. 2004. Vol. 25, No 28. P. 5929-5938. DOI: 10.1016/j.biomaterials.2004.01.044.
  • Maldonado M., Nam J. The role of changes in extracellular matrix of cartilage in the presence of inflammation on the pathology of osteoarthritis // Biomed. Res. Int. 2013. Vol. 2013. P. 284873. DOI: 10.1155/2013/284873.
  • Goldring M.B., Otero M. Inflammation in osteoarthritis // Curr. Opin. Rheumatol. 2011. Vol. 23, No 5. P. 471-478. DOI: 10.1097/ BOR.0b013e328349c2b1.
  • AMPA/kainate glutamate receptors contribute to inflammation, degeneration and pain related behaviour in inflammatory stages of arthritis / C.S. Bonnet, A.S. Williams, S.J. Gilbert, A.K. Harvey, B.A. Evans, D.J. Mason // Ann. Rheum. Dis. 2015. Vol. 74, No 1. P. 242-251. DOI: 10.1136/ annrheumdis-2013-203670.
  • Roles of inflammatory and anabolic cytokines in cartilage metabolism: signals and multiple effectors converge upon MMP-13 regulation in osteoarthritis / M.B. Goldring, M. Otero, D.A. Plumb, C. Dragomir, M. Favero, K. El Hachem, K. Hashimoto, H.I Roach, E. Olivotto, R.M. Borzi, K.B. Marcu// Eur. Cell Mater. 2011. Vol. 21. P. 202-220. DOI: 10.22203/ecm.v021a16.
  • Exosomes from IL-1ß stimulated synovial fibroblasts induce osteoarthritic changes in articular chondrocytes / T. Kato, S. Miyaki, H. Ishitobi, Y. Nakamura, T. Nakasa, M.K. Lotz, M. Ochi // Arthritis Res. Ther. 2014. Vol. 16, No 4. P. R163. DOI: 10.1186/ar4679.
  • Andersen H.H., Duroux M., Gazerani P. MicroRNAs as modulators and biomarkers of inflammatory and neuropathic pain conditions // Neurobiol. Dis. 2014. Vol. 71. P. 159-168. doi: 10.1016/j.nbd.2014.08.003.
  • Gender-specific differential expression of exosomal miRNA in synovial fluid of patients with osteoarthritis / R. Kolhe, M. Hunter, S. Liu, R.N. Jadeja, C. Pundkar, A.K Mondal, B. Mendhe, M. Drewry, M.V. Rojiani, Y. Liu, C.M. Isales, R.E. Guldberg, M.W. Hamrick, S. Fulzele // Sci. Rep. 2017. Vol. 7, No 1. P. 2029. DOI: 10.1038/s41598-017-01905-y.
  • Selective loading of exosomal HULC and miR-372 is responsible for chondrocyte death during OA pathogenesis / J. Song, Y. Kang, C.H. Chun, E.I. Jin // Animal Cells Syst (Seoul). 2017. Vol. 21, No 6. P. 397-403. DOI: 10.1080/19768354.2017.1406871.
  • Extracellular Vesicles in the Synovial Joint: Is there a Role in the Pathophysiology of Osteoarthritis? / A. Esa, K.D. Connolly, R. Williams, C.W. Archer // Malays. Orthop. J. 2019. Vol. 13, No 1. P. 1-7. DOI: 10.5704/MOJ.1903.012.
  • Phinney D.G., Pittenger M.F. Concise Review: MSC-Derived Exosomes for Cell-Free Therapy // Stem Cells. 2017. Vol. 35, No 4. P. 851-858. DOI: 10.1002/stem.2575.
  • Efficacy of mesenchymal stem cells in treating patients with osteoarthritis of the knee: A meta-analysis / G. Cui, Y.Y. Wang, C.J. Li, C.H. Shi, W.S. Wang // Exp. Ther. Med. 2016. Vol. 12, No 5. P. 3390-3400. DOI: 10.3892/etm.2016.3791.
  • Secreted Factors and EV-miRNAs Orchestrate the Healing Capacity of Adipose Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis / E. Ragni, O.C. Perucca, P. De Luca, A. Colombini, M. Vigano, L. de Girolamo // Int. J. Mol. Sci. 2020. Vol. 21, No 5. P. 1582. DOI: 10.3390/ ijms21051582.
  • Comparison of exosomes secreted by induced pluripotent stem cell-derived mesenchymal stem cells and synovial membrane-derived mesenchymal stem cells for the treatment of osteoarthritis / Y. Zhu, Y. Wang, B. Zhao, X. Niu, B. Hu, Q. Li, J. Zhang, J. Ding, Y. Chen, Y. Wang // Stem Cell Res. Ther. 2017. Vol. 8, No 1. P. 64. DOI: 10.1186/s13287-017-0510-9.
  • Interaction with hyaluronan matrix and miRNA cargo as contributors for in vitro potential of mesenchymal stem cell-derived extracellular vesicles in a model of human osteoarthritic synoviocytes / E. Ragni, O.C. Perucca, P. De Luca, G. Lugano, M. Vigano, A. Colombini, F. Valli, D. Zacchetti, V. Bollati, L. de Girolamo // Stem Cell Res.Ther. 2019. Vol. 10, No. 1. P. 109. DOI: 10.1186/s13287-019-1215-z.
  • Xiao L., Williams D., Hurley M.M. Inhibition of FGFR Signaling Partially Rescues Osteoarthritis in Mice Overexpressing High Molecular Weight FGF2 Isoforms // Endocrinology. 2020. Vol. 161, No 1. P. bqz016. DOI: 10.1210/endocr/bqz016.
  • A novel FGFR1-binding peptide attenuates the degeneration of articular cartilage in adult mice / Q. Tan, B. Chen, Q. Wang, W. Xu, Y. Wang, Z. Lin, F. Luo, S. Huang, Y. Zhu, N. Su, M. Jin, C. Li, L. Kuang, H. Qi, Z. Ni, Z. Wang, X. Luo, W. Jiang, H. Chen, S. Chen, F. Li, B. Zhang, J. Huang, R. Zhang, K. Jin, X. Xu, C. Deng, X. Du, Y. Xie, L. Chen // Osteoarthritis Cartilage. 2018. Vol. 26, No 12. P. 1733-1743. DOI: 10.1016/j. joca.2018.08.012.
  • Herrmann I.K., Wood M.J.A., Fuhrmann G. Extracellular vesicles as a next-generation drug delivery platform // Nat. Nanotechnol. 2021. Vol. 16, No. 7. P. 748-759. DOI: 10.1038/s41565-021-00931-2.
  • Extracellular Vesicle Nanoarchitectonics for Novel Drug Delivery Applications / S. Sharma, M.K. Masud, Y.V. Kaneti, P. Rewatkar, A. Koradia, M.S.A. Hossain, Y. Yamauchi, A. Popat, C. Salomon // Small. 2021. Vol. 17, No 42. P. e2102220. DOI: 10.1002/smll.202102220.
  • Microvesicles transfer mitochondria and increase mitochondrial function in brain endothelial cells / A. D'Souza, A. Burch, K.M. Dave, A. Sreeram, M.J. Reynolds, D.X. Dobbins, Y.S. Kamte, W. Zhao, C. Sabatelle, G.M. Joy, V. Soman, U.R. Chandran, S.S. Shiva, N. Quillinan, P.S. Herson, D.S. Manickam// J. Control. Release. 2021. Vol. 338. P. 505-526. DOI: 10.1016/j.jconrel.2021.08.038.
  • Extracellular Vesicles as an Advanced Delivery Biomaterial for Precision Cancer Immunotherapy / S. Ruan, Z. Greenberg, X. Pan, P. Zhuang, N. Erwin, M. He // Adv. Healthc. Mater. 2021. P. e2100650. DOI: 10.1002/adhm.202100650.
  • Csanaky K., Hess M.W., Klimaschewski L. Membrane-Associated, Not Cytoplasmic or Nuclear, FGFR1 Induces Neuronal Differentiation // Cells. 2019. Vol. 8, No 3. P. 243. DOI: 10.3390/cells8030243.
  • Fibroblast growth factor receptor 1 gene amplification and protein expression in human lung cancer / O. Elakad, A.M. Lois, K. Schmitz, S. Yao, S. Hugo, L. Lukat, M. Hinterthaner, B.C. Danner, A. Hammerstein-Equord, K. Reuter-Jessen, H.U. Schildhaus, P. Ströbel, H. Bohnenberger // Cancer Med. 2020. Vol. 9, No 10. P. 3574-3583. DOI: 10.1002/cam4.2994.
  • Preselection of Lung Cancer Cases Using FGFR1 mRNA and Gene Copy Number for Treatment With Ponatinib / T.L. Ng, H. Yu, D.E. Smith, T.A. Boyle, E.R. York, S. Leedy , D. Gao, D.L. Aisner, A. van Bokhoven, L.E. Heasley, F.R. Hirsch, D.R. Camidge // Clin. Lung Cancer. 2019. Vol. 20, No 1. P. e39-e51. DOI: 10.1016/j.cllc.2018.09.001.
  • Herrmann I.K., Wood M.J.A., Fuhrmann G. Extracellular vesicles as a next-generation drug delivery platform // Nat. Nanotechnol. 2021. Vol. 16, No 7. P. 748-759. DOI: 10.1038/s41565-021-00931-2.
  • Progress in exosome isolation techniques / P. Li, M. Kaslan, S.H. Lee, J. Yao, Z. Gao // Theranostics. 2017. Vol. 7, No 3. P. 789-804. DOI: 10.7150/ thno.18133.
Еще
Статья научная
SciUp 2024 © 2024 ©